Krystal Biotech, Inc. (KRYS) earnings
KRYS earnings moved a median of +0.27% by the close. Quarterly and annual KRYS reports and results, each read against the price at its own news timestamp. Back to the KRYS overview →
30 measured KRYS earnings events.
Where these KRYS earnings landedvs 29 measured KRYS earnings reactions
| Middle 50% of KRYS earnings reactions | -2.48% to +7.86% |
|---|---|
| Median reaction (to close) | +0.27% |
| Measured reactions | 29 |
Point-in-time · zero look-ahead
Half of the 29 KRYS earnings events with a measured close landed between -2.48% and +7.86%; 59% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Form 10-Q Krystal Biotech, Inc. For: Jun 30 | SEC filing · Form 10-Q | +0.51% | -2.54% | |
| Krystal Biotech Announces Second Quarter 2026 Financial and Operating Results | Press release | +0.51% | -2.54% | |
| Krystal Biotech to Report Second Quarter 2026 Financial Results on August 3, 2026 | Press release | -0.18% | +2.33% | |
| Form 10-Q Krystal Biotech, Inc. For: Mar 31 | SEC filing · Form 10-Q | -2.78% | +8.04% | |
| Krystal Biotech Announces First Quarter 2026 Financial and Operating Results | Press release | -2.78% | +8.04% | |
| Krystal Biotech to Report First Quarter 2026 Financial Results on May 4, 2026 | Press release | +0.00% | -1.73% | |
| Form 10-K Krystal Biotech, Inc. For: Dec 31 | SEC filing · Form 10-K | +0.35% | -0.40% | |
| Form 10-Q Krystal Biotech, Inc. For: Sep 30 | SEC filing · Form 10-Q | -1.70% | +0.27% | |
| Krystal Biotech Announces Third Quarter 2025 Financial and Operating Results | Press release | -1.70% | +0.27% | |
| Krystal Biotech to Report Third Quarter 2025 Financial Results on November 3, 2025 | Press release | +0.20% | -2.26% | |
| Form 10-Q Krystal Biotech, Inc. For: Jun 30 | SEC filing · Form 10-Q | -9.63% | -12.26% | |
| Krystal Biotech Announces Second Quarter 2025 Financial and Operating Results | Press release | -9.63% | -12.26% | |
| Krystal Biotech to Report Second Quarter 2025 Financial Results on August 4, 2025 | Press release | -0.60% | — | |
| Form 10-Q Krystal Biotech, Inc. For: Mar 31 | SEC filing · Form 10-Q | -1.16% | -2.48% | |
| Krystal Biotech Announces First Quarter 2025 Financial and Operating Results | Press release | -1.16% | -2.48% | |
| Krystal Biotech to Report First Quarter 2025 Financial Results on May 6, 2025 | Press release | -1.09% | +2.23% | |
| Form 10-K Krystal Biotech, Inc. For: Dec 31 | SEC filing · Form 10-K | +5.67% | +17.53% | |
| Form 10-Q Krystal Biotech, Inc. For: Sep 30 | SEC filing · Form 10-Q | +0.04% | +3.64% | |
| Krystal Biotech Announces Third Quarter 2024 Financial Results and Provides Business Updates | Press release | +0.04% | +3.64% | |
| Krystal Biotech to Report Third Quarter 2024 Financial Results on November 4, 2024 | Press release | +0.00% | -0.21% | |
| Form 10-Q Krystal Biotech, Inc. For: Jun 30 | SEC filing · Form 10-Q | +3.15% | +9.65% | |
| Krystal Biotech Announces Second Quarter 2024 Financial Results and Provides Business Updates | Press release | +3.15% | +9.65% | |
| Krystal Biotech to Report Second Quarter 2024 Financial Results on August 5, 2024 | Press release | +1.04% | +0.20% | |
| Form 10-Q Krystal Biotech, Inc. For: Mar 31 | SEC filing · Form 10-Q | +3.11% | +7.86% | |
| Krystal Biotech Announces First Quarter 2024 Financial Results and Provides Business Updates | Press release | +3.11% | +7.86% | |
| Krystal Biotech to Report First Quarter 2024 Financial Results on May 6, 2024 | Press release | +1.70% | +0.38% | |
| Form 10-K Krystal Biotech, Inc. For: Dec 31 | SEC filing · Form 10-K | +4.11% | +23.85% | |
| Form 10-Q Krystal Biotech, Inc. For: Sep 30 | SEC filing · Form 10-Q | -7.53% | -7.35% | |
| Krystal Biotech Announces Third Quarter 2023 Financial Results and Provides Business Update | Press release | -7.53% | -7.35% | |
| Krystal Biotech to Report Third Quarter 2023 Financial Results on November 6, 2023 | Press release | +1.85% | +2.98% |
Keep exploring
More KRYS: analyst actions → · SEC filings → · KRYS overview →
Other Healthcare names and their earnings
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| Cue Biopharma, Inc. (CUE) | 251 | -0.05% | 50% |
| DOVA PHARMACEUTICALS (DOVA) | 251 | -0.10% | 46% |
| Mersana Therapeutics, Inc. (MRSN) | 251 | -0.20% | 46% |
| Soligenix, Inc. (SNGX) | 251 | -0.71% | 35% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not. These are each name’s all-news baseline, not its earnings — that is what the link opens.